Bin Cao
Impact in
- Infectious Diseases top 0.01%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 0.01%
- Long-Term Effects of COVID-19
Papers in
- Epidemiology 159
- Pneumonia and Respiratory Infections 67
- Influenza Virus Research Studies 56
- Respiratory viral infections research 48
-
- COVID-19 Clinical Research Studies 45
- SARS-CoV-2 and COVID-19 Research 33
- Antimicrobial Resistance in Staphylococcus 14
- Co-authors
- Jiuyang Xu (25 shared papers)Yeming Wang (31 shared papers)Ronghui Du (2 shared papers)Xiaoying Gu (25 shared papers)Guohui Fan (16 shared papers)Fei Zhou (8 shared papers)Xudong Wu (2 shared papers)Yuan Wei (2 shared papers)
- Journals
- The Lancet (16 papers)BMC Infectious Diseases (12 papers)The Lancet Infectious Diseases (10 papers)International Journal of Infectious Diseases (9 papers)International Journal of Antimicrobial Agents (8 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bin Cao
384 papers receiving 82.8k citations
Bin Cao's Hit Papers
Peers
Comparison fields: 5 of 218
- Infectious Diseases 40.5k
- Neurology 16.4k
- Modeling and Simulation 4.1k
- Applied Microbiology and Biotechnology 1.1k
- Critical Care and Intensive Care Medicine 2.8k
Countries citing papers authored by Bin Cao
This map shows the geographic impact of Bin Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Cao more than expected).
Fields of papers citing papers by Bin Cao
This network shows the impact of papers produced by Bin Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Cao. The network helps show where Bin Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 410 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Hit paper breakdown → | 2020 | 35595 |
| 2 | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Hit paper breakdown → | 2020 | 20352 |
| 3 | A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 Hit paper breakdown → | 2020 | 4028 |
| 4 | Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial Hit paper breakdown → | 2020 | 2707 |
| 5 | Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus Hit paper breakdown → | 2013 | 2061 |
| 6 | Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study Hit paper breakdown → | 2018 | 1209 |
| 7 | Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study Hit paper breakdown → | 2020 | 952 |
| 8 | SARS-CoV-2 and viral sepsis: observations and hypotheses Hit paper breakdown → | 2020 | 908 |
| 9 | 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study Hit paper breakdown → | 2021 | 803 |
| 10 | Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection Hit paper breakdown → | 2013 | 558 |
| 11 | Prevalence, risk factors, and management of asthma in China: a national cross-sectional study Hit paper breakdown → | 2019 | 540 |
| 12 | Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data Hit paper breakdown → | 2014 | 515 |
| 13 | Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China Hit paper breakdown → | 2009 | 498 |
| 14 | 2020 | 495 | |
| 15 | Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study Hit paper breakdown → | 2022 | 433 |
| 16 | Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections Hit paper breakdown → | 2017 | 418 |
| 17 | Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data Hit paper breakdown → | 2021 | 386 |
| 18 | Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network Hit paper breakdown → | 2017 | 362 |
| 19 | Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis Hit paper breakdown → | 2017 | 360 |
| 20 | 2018 | 305 |
About Bin Cao
Bin Cao is a scholar working on Epidemiology, Infectious Diseases, Molecular Medicine, Neurology and Critical Care and Intensive Care Medicine, having authored 410 papers that have together received 85.2k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (67 papers), Influenza Virus Research Studies (56 papers), Respiratory viral infections research (48 papers), COVID-19 Clinical Research Studies (45 papers), Antibiotic Resistance in Bacteria (40 papers), Long-Term Effects of COVID-19 (35 papers), SARS-CoV-2 and COVID-19 Research (33 papers) and Antimicrobial Resistance in Staphylococcus (14 papers). The work is most often cited by research in Infectious Diseases (40.5k citations), Neurology (16.4k citations), Modeling and Simulation (4.1k citations), Applied Microbiology and Biotechnology (1.1k citations) and Critical Care and Intensive Care Medicine (2.8k citations). Bin Cao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jiuyang Xu, Yeming Wang, Ronghui Du, Xiaoying Gu, Guohui Fan, Fei Zhou, Xudong Wu, Yuan Wei, Shengjin Tu and Bin Song. Their work appears in journals such as The Lancet, BMC Infectious Diseases, The Lancet Infectious Diseases, International Journal of Infectious Diseases and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.